Themis announces Iain Dukes to join the company’s supervisory board17. April 2020|In Portfolio News|By eazee-designstudioDr. Dukes has amassed over 20 years in leadership roles at large pharmaceutical and biotechnology companies. As Themis transitions towards rapidly ramping up the development of a coronavirus vaccine candidate towards the clinic in response to the global pandemic and being prepared to supply the initial stockpiles of its vaccine, Dr. Dukes’ background will further enhance the range of experience on the Company’s Board. PrevNext
